P A Bunn

SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCER

DesmondN. Carney, DanielC Ihde, MartinH Cohen et al. · The Lancet · 1982 · 386 citations

Medicine, Cancer Biology, Oncology +7

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.

Austin Doyle, Martin Wj, Keiko Funa et al. · The Journal of Experimental Medicine · 1985 · 383 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

Dennis J. Ahnen, Polly Feigl, G. Quan et al. · PubMed · 1998 · 349 citations · Full text

Medicine, Oncology, Pathology +17

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Fred R. Hirsch, Marileila Varella‐Garcia, Federico Cappuzzo et al. · Annals of Oncology · 2007 · 270 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Small Cell Carcinoma Presenting as an Extrapulmonary Neoplasm: Sites of Origin and Response to Chemotherapy<xref ref-type="fn" rid="fn2">2</xref>

Robert M. Levenson, D C Ihde, Mary J. Matthews et al. · JNCI Journal of the National Cancer Institute · 1981 · 149 citations · Full text

Medicine, Oncology, Chemotherapy +15